Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,042 | 234 | 88.8% |
| Unspecified | $500.00 | 1 | 11.0% |
| Education | $10.66 | 2 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $638.15 | 38 | $0 (2021) |
| Lucid Diagnostics Inc. | $558.38 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $369.41 | 28 | $0 (2021) |
| GlaxoSmithKline, LLC. | $301.98 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $295.98 | 18 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $293.97 | 12 | $0 (2021) |
| ABBVIE INC. | $272.97 | 17 | $0 (2024) |
| Novo Nordisk Inc | $238.55 | 12 | $0 (2024) |
| PFIZER INC. | $207.00 | 13 | $0 (2024) |
| Shire North American Group Inc | $179.12 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $621.00 | 8 | Lucid Diagnostics Inc. ($530.03) |
| 2023 | $183.87 | 7 | Inspire Medical Systems, Inc. ($42.16) |
| 2022 | $233.15 | 14 | ABBVIE INC. ($110.59) |
| 2021 | $702.10 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($116.89) |
| 2020 | $815.90 | 44 | Janssen Pharmaceuticals, Inc ($279.99) |
| 2019 | $1,000 | 58 | AstraZeneca Pharmaceuticals LP ($161.36) |
| 2018 | $654.45 | 41 | Merck Sharp & Dohme Corporation ($135.65) |
| 2017 | $342.07 | 27 | Janssen Pharmaceuticals, Inc ($119.35) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: VACCINES | ||||||
| 04/16/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $14.57 | General |
| 03/26/2024 | Lucid Diagnostics Inc. | — | — | Cash or cash equivalent | $500.00 | Research |
| Study: Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled | ||||||
| 02/29/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $9.33 | General |
| 01/31/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $6.13 | General |
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Obesity | ||||||
| 12/10/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 11/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Oncology | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.98 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Obesity | ||||||
| 06/15/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $42.16 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2022 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: EndoVenous Therapies | ||||||
| 05/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2022 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: VACCINES | ||||||
| 04/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $13.55 | General |
| 04/25/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled | Lucid Diagnostics Inc. | $500.00 | 1 |
About Dr. Michael Phelps, MD
Dr. Michael Phelps, MD is a Family Medicine healthcare provider based in Tigard, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1699060780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Phelps, MD has received a total of $4,553 in payments from pharmaceutical and medical device companies, with $621.00 received in 2024. These payments were reported across 237 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,042).
Practice Information
- Specialty Family Medicine
- Location Tigard, OR
- Active Since 06/16/2011
- Last Updated 02/03/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699060780
Products in Payments
- INVOKANA (Drug) $380.08
- XARELTO (Drug) $252.05
- VYVANSE (Drug) $180.01
- UBRELVY (Drug) $167.87
- FARXIGA (Drug) $162.95
- JARDIANCE (Drug) $161.88
- SHINGRIX (Biological) $155.40
- TRADJENTA (Drug) $134.35
- Trintellix (Drug) $126.93
- JANUVIA (Drug) $102.15
- BYDUREON (Drug) $99.95
- CHANTIX (Drug) $98.20
- Dayvigo (Drug) $96.72
- NEXPLANON (Drug) $89.07
- QULIPTA (Drug) $88.32
- Aimovig (Biological) $86.92
- MYDAYIS (Drug) $78.11
- BEXSERO (Biological) $74.19
- Ozempic (Drug) $65.18
- NURTEC ODT (Drug) $53.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tigard
Andrea Tremaine, Md, MD
Family Medicine — Payments: $5,229
Dr. Standley Adamek, Do, DO
Family Medicine — Payments: $4,963
Mrs. Cynthia Gulick, Do, DO
Family Medicine — Payments: $3,721
Stephen Babson
Family Medicine — Payments: $1,847
Dr. Kristine Griess, D.o, D.O
Family Medicine — Payments: $1,159
Walter Goebel, Md, MD
Family Medicine — Payments: $986.68